Navigation Links
Rx Response Raised to 'Alert Status' in Response to Growing Swine Flu Threat
Date:4/29/2009

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- Rx Response, an unprecedented partnership created to help ensure the continued flow of medicines to patients in a severe public health emergency, has been put on Alert Status as concerns grow over the health threat posed by outbreaks of swine flu in the United States.

"Americans need to know that the medicines they rely on will be available even in an emergency," said Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), a member of Rx Response. "Rx Response provides federal and state crisis managers with the critical information they need about the pharmaceutical supply chain to help communities affected by an emergency return to normal as quickly as possible."

Alert Status means that Rx Response members are now closely monitoring developing information regarding influenza cases detected in the United States and are working with local, state and federal health authorities to help ensure the continued efficient functioning of the nation's pharmaceutical supply chain.

Over the past 48 hours, Rx Response officials have been in contact with federal and state health officials to share information about the pharmaceutical supply system's pandemic response capabilities.

For the most up to date information on the status of the swine flu influenza investigation, please visit: http://www.cdc.gov/swineflu/ .

Rx Response was developed more than 2 years ago in response to Hurricane Katrina and the threat of pandemic influenza. Rx Response members include:

  • American Hospital Association (AHA)
  • American Red Cross
  • Biotechnology Industry Organization (BIO)
  • Generic Pharmaceutical Association (GPhA)
  • Healthcare Distribution Management Association (HDMA)
  • National Association of Chain Drug Stores (NACDS)
  • National Community Pharmacists Association (NCPA)
  • Pharmaceutical Research and Manufacturers of America (PhRMA)

Rx Response is a single point of contact for the entire pharmaceutical supply system and relies on a robust network that allows federal and state emergency management officials to communicate with Rx Response regarding pharmaceutical needs and other issues which may impact the supply system. The communications are actively monitored by all segments of the pharmaceutical supply system to ensure the fastest possible resolution.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the dangers of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Study identifies key player in the bodys immune response to chronic stress
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
5. Merck & Co., Inc. Response to Todays New York Medicaid Suit
6. Maternal depression and controlling behavior associated with increased stress response in infants
7. Family history of alcoholism affects response to drug used to treat heavy drinking
8. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
9. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
10. PET scans can accurately detect a breast tumors response to chemotherapy
11. DNA damage response confers a barrier for viral tumorigenesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... TX (PRWEB) , ... September 20, 2017 , ... ... date of the much-anticipated fall event , Look Awesome This Autumn with ... personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique is ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... Orthodontics and Clear Aligner clinical and commercial support services market) has entered into ... (PGSD) in Sydney, Australia. , The PGSD is the first private Dental ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is proud to ... Guard®, has helped another long-time client pass their Department of Health and Human ... law. , Thanks to the help of the Compliancy Group's Audit Response Program™, ...
(Date:9/20/2017)... ... ... In just a short time since going on sale on Wal-Mart Stores-owned ... trying the product for the first time, and others who had already been using ... Moore, MD, for everyone from athletes at risk from multiple concussions to elderly consumers ...
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products were ... 27 different categories. Nopavera Plus was named to the short list in ... SupplySide West 2017 during presentations at SupplySide Central on Sept. 27 and 28 at ...
Breaking Medicine News(10 mins):
(Date:9/13/2017)... has been named the official orthopedic and sports medicine ... 2018 College Football Playoff (CFP) National Championship to be played ... Atlanta, Georgia . OrthoAtlanta is proud to be ... many activities leading up to, and including the national championship ... OrthoAtlanta serves ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
Breaking Medicine Technology: